Erratum: Department of Error (Successes and challenges of HIV prevention in men who have sex with men (2012) 380(9839) (388–399), (S0140673612609556), (10.1016/S0140-6736(12)60955-6));Successes and challenges of HIV prevention in men who have sex with men

The Lancet

Volumn 380, Issue 9839, 2012, Pages 388-399

  Sullivan, Patrick S ^a   Carballo Diéguez, Alex ^b   Coates, Thomas ^c   Goodreau, Steven M ^d   McGowan, Ian ^e   Sanders, Eduard J ^f,g   Smith, Adrian ^g   Goswami, Prabuddhagopal ^h   Sanchez, Jorge ⁱ  

^a EMORY UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h FAMILY HEALTH INTERNATIONAL   (United States)

ⁱ ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; PLACEBO; TENOFOVIR;

ANTIVIRAL THERAPY; ANUS INTERCOURSE; ARTICLE; BEHAVIOR CHANGE; CONDOM; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE ACCESS; HIV SEROSORTING; HIV TEST; HOMOPHOBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE HOMOSEXUAL; NAUSEA; PRIORITY JOURNAL; PROSTITUTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCALE UP; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; VACCINATION; VIRUS LOAD; WEIGHT REDUCTION;

EID: 84864285679     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61251-3     Document Type: Erratum

References (95)

1. Centers for Disease Control and Prevention. Pneumocystis Pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30: 1-3.
2. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA 2007; 298: 2412-14. (Pubitemid 350190783)
3. Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet 2009; 374: 416-22.
4. van Griensven F, de Lind van Wijngaarden JW, Baral S, Grulich A. The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 2009; 4: 300-07.
5. Baral S, Wirtz A, Sifakis F, Johns B, Walker D, Beyrer C. The highest attainable standard of evidence (HASTE) for HIV/AIDS interventions: towards a public health approach to defining evidence. Public Health Rep (in press).
6. WHO. Guidelines: prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recommendations for a public health approach. http://www.who.int/hiv/pub/ guidelines/msm-guidelines2011/en/ (accessed Jan 12, 2012).
7. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372: 669-84.
8. Johnson WD, Holtgrave DR, McClellan WM, Flanders WD, Hill AN, Goodman M. HIV intervention research for men who have sex with men: a 7-year update. AIDS Educ Prev 2005; 17: 568-89. (Pubitemid 43061822)
9. Koblin BA, The EXPLORE Study Team. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 2004; 364: 41-50.
10. Winkelstein W, Samuel M, Padian NW, Wiley JA. Selected sexual practices of San Francisco heterosexual men and risk of infection by the human immunodeficiency virus. JAMA 1987; 257: 1470-71.
11. Winkelstein W, Wiley JA, Padian NS. The San Francisco men's health study: continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health 1988; 78: 1472-74. (Pubitemid 18259689)
12. Winkelstein W, Samuel M, Padian NS. The San Francisco men's health study III: reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health 1987; 77: 685-89. (Pubitemid 17084507)
13. Kippax S, Race K. Sustaining safe practice: twenty years on. Soc Sci Med 2003; 57: 1-12. (Pubitemid 36566515)
14. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300: 520-29.
15. Centers for Disease Control and Prevention. 2009 compendium of HIV prevention interventions. http://www.cdc.gov/hiv/topics/research/prs/evidence- based-interventions.htm (accessed June 20, 2012).
16. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M-L. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 11: 942-51.
17. Li D, Jia Y, Ruan Y, et al. Correlates of incident infections for HIV, syphilis, and hepatitis B virus in a cohort of men who have sex with men in Beijing. AIDS Pat Care STD 2010; 24: 595-602.
18. Baral S, Trapence G, Motimedi F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS One 2009; 4: e4997.
19. Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2004; 140: 557-68.
20. Shoptaw S, Klausner J, Reback C, et al. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006; 6: 214.
21. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010; 376: 285-301.
22. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Sys Rev 2009; 2002: CD003255.
23. Vitinghoff E, Douglas J, Judon F, McKiman D, MacQueen K, Buchinder SP. Per-contact risk of human immunodificiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150: 306-11. (Pubitemid 29344958)
24. Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse: a review. Sex Transm Dis 1997; 24: 11-17. (Pubitemid 27030472)
25. Stone E, Heagerty P, Vittinghoff E, et al. Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 495-501. (Pubitemid 29198290)
26. Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts, 16th International AIDS Conference epidemiology plenary. ClinInfect Dis 2007; 44: 981-87. (Pubitemid 46452067)
27. Renzi C, Tabet SR, Stucky JA, et al. Safety and acceptability of the RealityTM condom for anal sex among men who have sex with men. AIDS 2003; 17: 727-31. (Pubitemid 36521079)
28. Butler LM, Osmond DH, Jones AG, Martin JN. Use of saliva as a lubricant in anal sexual practices among homosexual men. J Acquir Immune Defic Syndr 2009; 50: 162-67.
29. Gorbach PM, Weiss RE, Fuchs E, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis 2012; 39: 59-64.
30. Russo J, Rohan LC, Moncla B, et al. Safety and anti-HIV activity of over-the-counter lubricant gels. Microbicides: building bridges in HIV prevention; Pittsburgh, PA, USA; May 22-25, 2010. 347.
31. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363: 2587-99.
32. Consensus Committee of the Southern African HIV Clinicians Society. Southern African guidelines for the safe use of preexposure prophylaxis in men who have sex with men who are at risk for HIV infection. S Afr J HIV Med. 2012; 13: 40-55.
33. Mansergh G, Koblin BA, Sullivan PS. Challenges for HIV pre-exposure prophylaxis in men who have sex with men in the United States. PLoS Med (in press).
34. Weber J, Tatoud R, Fidler S. Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. AIDS 2010; 24: S27-39.
35. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375: 2092-98.
36. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23: 1397-404.
37. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5: e11068.
38. Law M, Woolley I, Templeton D, et al. Trends in detectable viral load by calendar year in the Australian HIV observational database. J International AIDS Soc 2011; 14: 10.
39. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011; 378: 256-68.
40. Fisher M, Pao D, Brown AE, et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010; 24: 1739-47.
41. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-26.
42. Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the US: the national HIV behavioral surveillance system. Public Health Rep 2007; 122 (suppl 1): 32-38. (Pubitemid 47450427)
43. McGowan I. Microbicides for HIV prevention: reality or hope? Curr Opin Infect Dis 2010; 23: 26-31.
44. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168-74.
45. Cranage M, Sharpe S, Herrera C, et al. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med 2008; 5: e157.
46. Carballo-Dieguez A, O'Sullivan L, Lin P, Dolezal C, Pollack L, Catania J. Awareness and attitudes regarding microbicides and nonoxynol-9 use in a probability sample of gay men. AIDS Behav 2007; 11: 271-76.
47. Carballo-Dieguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis 2007; 34: 224-29. (Pubitemid 46606747)
48. Anton P, Cranston R, Carballo-Dieguez A, et al. RMP-02/MTN-006: a phase 1 placebo-controlled trial of rectally applied 1% vaginal TFV gel with comparison to oral TDF. 18th conference on retroviruses and opportunistic infections; Boston, MA, USA; Feb 27-March 2, 2011. 34LB.
49. McGowan I, Hoesley C, Andrew P, et al. MTN-007: A Phase 1 randomized, double-blind, placebo-controlled, rectal safety and acceptability study of tenofovir 1% gel. 19th Conference on Retroviruses and Opportunistic Infections; Seattle, WA; March 5-8, 2012. 34LB.
50. McGowan I. Rectal microbicides: can we make them and will people use them? AIDS Behav 2011; 15 (suppl 1): S66-71.
51. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372: 1881-93.
52. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med 2009; 361: 2209-20.
53. Excler J-L, Rida W, Priddy F, et al. AIDS vaccines and preexposure prophylaxis: is synergy possible? AIDS Res Human Retroviruses 2011; 27: 669-80.
54. Cranage M, Sharpe S, Herrera C, et al. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med 2008; 5: e157.
55. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39: 446-53. (Pubitemid 41003791)
56. Centers for Disease Control and Prevention. Prevalence and awareness of HIV infection among men who have sex with men-21 cities, United States, 2008. MMWR Morb Mort Wkly Rep 2010; 59: 1201-07.
57. Lane T, Raymond HF, Dladla S, et al. High HIV prevalence among men who have sex with men in Soweto, South Africa: results from the Soweto men's study. AIDS Behav 2011; 15: 626-34.
58. Chin-Hong P, Husnik M, Cranston R, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009; 23: 1135-42.
59. Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006; 164: 733-41. (Pubitemid 44522078)
60. Politch JA, Mayer KH, Welles SL, et al. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS 2012; published online March 21. DOI:10.1097/QAD.0b013e328353b11b.
61. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Science Translat Med 2011; 3: 77ra29.
62. Padian NS, Buve A, Balkus J, Serwadda D, Cates W. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 2008; 372: 585-99.
63. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 2109-19. (Pubitemid 351902179)
64. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362: 427-39.
65. Menza TW, Hughes JP, Celum CL, Golden MR. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009; 36: 547-55.
66. Dieffenbach CW, Fauci AS. Thirty years of HIV and AIDS: future challenges and opportunities. Ann Intern Med 2011; 154: 766-71.
67. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60. (Pubitemid 28135961)
68. Beyrer C, Baral SD, van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet 2012; published online July 20. http://dx.doi.org/10.1016/S0140-6736(12)60821-6.
69. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
70. Eshleman SH, Hudelson SE, Redd AD, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial. J Infect Dis 2011; 204: 1918-26.
71. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363: 2587-99.
72. Wilton L, Herbst JH, Coury-Doniger P, et al. Efficacy of an HIV/STI prevention intervention for black men who have sex with men: findings from the many men, many voices (3MV) project. AIDS Behav 2009; 13: 532-44.
73. Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol 2008; 27: 159-69. (Pubitemid 351635823)
74. Charania MR, Crepaz N, Guenther-Gray C, et al. Efficacy of structural-level condom distribution interventions: a meta-analysis of US and international studies, 1998-2007. AIDS Behav 2010; 15: 1283-97.
75. Beyrer C, Sullivan PS, Sanchez J, et al. A call to action for comprehensive HIV services for men who have sex with men. Lancet 2012; published online July 20. http://dx.doi.org/10.1016/S0140-6736(12)61022-8.
76. MacQueen KM, Cates W. The multiple layers of prevention science research. Am J Prev Med 2005; 28: 491-95. (Pubitemid 40719051)
77. Kurth A, Celum C, Baeten J, Vermund S, Wasserheit J. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 2011; 8: 62-72.
78. Padian NS, McCoy SI, Manian S, Wilson D, Schwartlander B, Bertozzi S. Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr 2011; 58: e23-28.
79. Verma R, Shekhar A, Khobragade S, et al. Scale-up and coverage of Avahan: a large-scale HIV-prevention programme among female sex workers and men who have sex with men in four Indian states. Sex Transm Infect 2010; 86 (suppl 1): i76-82.
80. Yamey G. Scaling up global health interventions: a proposed framework for success. PLoS Med 2011; 8: e1001049.
81. Adam PCG, de Wit JBF, Toskin I, et al. Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries. J Acquir Immune Defic Syndr 2009; 52: S143-51.
82. Schmidt AJ, Benvenuti S, Breveglieri M, et al, for the EMIS consortium. The European MSM internet survey (EMIS) UNGASS indicators. http://www.emis- project.eu/sites/default/files/public/publications/EMIS-UNGASS-eng.pdf (accessed June 20, 2012).
83. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2006. Sydney, NSW: Kirby Institute for Infection and Immunity in Society, 2006.
84. Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ 2006; 55: 1-16.
85. Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis AIDS 2009; 23: 107-15.
86. Smith D. Africa calling: mobile phone usage sees record rise after huge investment. http://www.guardian.co.uk/technology/2009/oct/22/africa-mobile- phones-usage-rise (accessed June 20, 2012).
87. Wade AS, Kane CT, Diallo PA, et al. HIV infection and sexually transmitted infections among men who have sex with men in Senegal. AIDS 2005; 19: 2133-40. (Pubitemid 41669002)
88. Wall KM, Khosropour CM, Sullivan PS. Offering of HIV screening to men who have sex with men by their health care providers and associated factors. J Int Assoc Physicians AIDS Care (Chic) 2010; 9: 284-88.
89. Sanders EJ, Graham SM, Okuku HS, et al. HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya. AIDS 2007; 21: 2513-20. (Pubitemid 350145183)
90. Beyrer C, Trapence G, Motimedi F, et al. Bisexual concurrency, bisexual partnerships, and HIV among southern African men who have sex with men. Sex Transm Infect 2010; 86: 323-27.
91. Geibel S, Luchters S, King'Ola N, Esu-Williams E, Rinyiru A, Tun W. Factors associated with self-reported unprotected anal sex among male sex workers in Mombasa, Kenya. Sex Transm Dis 2008; 35: 746-52.
92. Fay H, Baral SD, Trapence G, et al. Stigma, health care access, and HIV knowledge among men who have sex with men in Malawi, Namibia, and Botswana. AIDS Behav 2010; 15: 1088-97.
93. Sanders E, Okuku H, Mwangome M, et al. Risk factors for HIV-1 infection among MSM in coastal Kenya. 18th Conference on Retroviruses and Opportunistic Infections (CROI); Boston, MA, USA; Feb 27-March 2, 2011. 1042
94. UNDP. Developing a comprehensive package of services to reduce HIV among men who have sex with men and transgender populations in Asia and the Pacific. http://www.snap-undp.org/elibrary/Publication.aspx?ID=655 (accessed Jan 12, 2012).
95. van Griensven F, de Lind van Wijngaarden JW. A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS 2010; 24 (suppl 3): S30-40.